サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375925

Gタンパク質共役型受容体の市場規模、シェア、動向分析レポート：製品タイプ別、アッセイタイプ別、用途別、地域別、セグメント別予測、2023年～2030年

G-Protein Coupled Receptors Market Size, Share & Trends Analysis Report By Product (Cell Lines, Detection Kits, Cell Culture Reagents, Ligands), By Assay Type, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 135 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
Gタンパク質共役型受容体の市場規模、シェア、動向分析レポート：製品タイプ別、アッセイタイプ別、用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年10月13日
発行: Grand View Research
ページ情報: 英文 135 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Gタンパク質共役型受容体市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のGタンパク質共役受容体市場規模は、CAGR 5.1％を記録し、2030年までに52億3,000万米ドルに達すると予測されています。

潜在的なGタンパク質共役型受容体（GPCR）を標的とした治療薬を開発するために、製薬会社がより迅速で正確なハイスループットスクリーニング（HTS）技術を採用する傾向が強まっており、市場成長の拡大が期待されています。HTSは、Gタンパク質共役受容体の細胞ベースのアッセイに使用され、いくつかの医薬品開発プログラムを支援します。

Gタンパク質共役型受容体（GPCR）の構造的・機能的特徴は、ホルモン、刺激物質、神経伝達物質に対する生理的反応を媒介することを可能にするため、様々な疾患の潜在的な治療標的となります。GPCRの構造生物学における最近の進歩により、これらの受容体の活性化と活性化の分子メカニズムに関する洞察が得られています。複数の製薬企業が、いくつかの疾患に対するGタンパク質共役受容体を標的とした治療薬の開発に取り組んでいます。

2018年12月、ベーリンガーインゲルハイムはDomain Therapeuticsと共同で、がん、中枢神経系（CNS）、免疫疾患の治療のためのGPCR標的を発見しました。さらに2019年5月、Evotec OAI AGはEuroscreen S.A.と提携し、GPCRターゲティングの能力を向上させました。Evotec OAIは創薬手順のためにEuroscreenのGPCR試薬とAequoScreenTM技術にアクセスします。このようなイニシアチブは、製薬業界における薬剤スクリーニングの専門知識だけでなく、製品の採用を強化します。

北米は、米国における創薬研究開発の需要増に対応するためのがん研究への投資が活発であるため、予測期間を通じて市場の最前線に立つと思われます。同地域では、治療薬開発と受託研究が増加しており、Gタンパク質共役型受容体市場の成長を後押ししています。

Gタンパク質共役型受容体市場レポートハイライト

  • 細胞株製品の入手が容易であり、様々な細胞株を提供する企業が多数存在することから、2022年の細胞株の売上高シェアが最大となっています。
  • 細胞株、試薬、リガンドを個別に使用する代わりに、完全装備の検出キットを使用するケースが増えており、近い将来、検出キットが成長する可能性を示しています。
  • cAMPアッセイは、GPCRの機能を説明するためのHTSにおける汎用性の高いプラットフォームとして機能し、その結果、このタイプのアッセイから最大の収益を生み出しています。
  • がん研究用途は、がん患者数の増加とがん研究開発への投資により、2022年に最大の収益シェアを占めました。
  • 慢性炎症性疾患におけるGPCRの薬理作用を評価するための継続的な調査研究により、炎症性アプリケーションの研究機会は計り知れないです。
  • 買収、提携、共同研究は、新しいGPCR標的医薬品を提供するためにこれらの企業が採用する主要な戦略であり、それによって世界のGPCR市場におけるプレゼンスを強化しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 Gタンパク質共役型受容体の市場変数、動向および範囲

  • 市場系統の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • Gタンパク質共役型受容体市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 Gタンパク質共役型受容体市場：製品推定・動向分析

  • Gタンパク質共役型受容体市場：重要なポイント
  • Gタンパク質共役型受容体市場：製品動向と市場シェア分析、2022年および2030年
  • 細胞株
  • 検出キット
  • 細胞培養試薬
  • リガンド

第5章 Gタンパク質共役型受容体市場：アッセイタイプの推定・動向分析

  • Gタンパク質共役型受容体市場：重要なポイント
  • Gタンパク質共役型受容体市場：アッセイタイプの動向と市場シェア分析、2022年および2030年
  • cAMP機能アッセイ
  • カルシウム機能アッセイ
  • B-アレスチン機能アッセイ
  • 放射性リガンド結合およびGTPγS機能アッセイ
  • 内部移行アッセイ
  • 人身売買アッセイ
  • その他のアッセイ

第6章 Gタンパク質共役型受容体市場：アプリケーションの推定・動向分析

  • Gタンパク質共役型受容体市場：重要なポイント
  • Gタンパク質共役型受容体市場：アプリケーションの動きと市場シェア分析、2022年および2030年
  • がん調査
  • 中枢神経系調査
  • 代謝調査
  • 心臓血管調査
  • 炎症調査
  • 呼吸器調査
  • その他の用途

第7章 Gタンパク質共役型受容体市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別のGタンパク質共役型受容体市場：重要なポイント
  • 北米
    • 北米市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州市場推計・予測、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋市場推計・予測、2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測、2018～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA市場推計・予測、2018年から2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Thermo Fisher Scientific Inc.
    • Eurofins Scientific
    • QIAGEN
    • WuXi AppTec
    • Promega Corporation
    • Abcam plc
    • Merck KGaA
    • PerkinElmer Inc.
    • Enzo Biochem Inc.
    • BD
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 4 North America G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 8 U.S. G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 9 Canada G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 11 Canada G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 12 Europe G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 14 Europe G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 18 Germany G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 19 UK G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 21 UK G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 22 France G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 23 France G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 24 France G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 25 Italy G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 27 Italy G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 28 Spain G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 30 Spain G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 31 Sweden G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 33 Sweden G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 34 Norway G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 36 Norway G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 37 Denmark G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 39 Denmark G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 44 China G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 45 China G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 46 China G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 47 Japan G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 49 Japan G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 50 India G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 51 India G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 52 India G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 53 Australia G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 55 Australia G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 56 Thailand G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 57 Thailand G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 58 Thailand G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Korea G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 61 South Korea G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 62 Latin America G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 64 Latin America G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 68 Brazil G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 69 Mexico G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 71 Mexico G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 72 Argentina G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 74 Argentina G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 81 South Africa G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 85 UAE G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 87 UAE G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 88 Kuwait G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait G-protein coupled receptors market, by assay type, 2018 - 2030 (USD Million)
  • Table 90 Kuwait G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 G-protein coupled receptors: market outlook
  • Fig. 9 G-protein coupled receptors competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 G-protein coupled receptors market driver impact
  • Fig. 15 G-protein coupled receptors market restraint impact
  • Fig. 16 G-protein coupled receptors market strategic initiatives analysis
  • Fig. 17 G-protein coupled receptors market: Product movement analysis
  • Fig. 18 G-protein coupled receptors market: Product outlook and key takeaways
  • Fig. 19 Cell lines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Detection kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Cell culture reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Ligands market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 G-protein coupled receptors market: Assay type movement analysis
  • Fig. 24 G-protein coupled receptors market: Assay type outlook and key takeaways
  • Fig. 25 cAMP functional assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Calcium functional assays market estimates and forecasts, 2018 - 2030
  • Fig. 27 B-Arrestin functional assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Radioligand binding and GTPγS functional assays market estimates and forecasts, 2018 - 2030
  • Fig. 29 Internalization assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Trafficking assays market estimates and forecasts, 2018 - 2030
  • Fig. 31 Other assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 G-protein coupled receptors market: Application movement analysis
  • Fig. 33 G-protein coupled receptors market: Application outlook and key takeaways
  • Fig. 34 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 CNS research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Metabolic research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Cardiovascular research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Inflammation research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Respiratory research market estimates and forecasts, 2018 - 2030
  • Fig. 40 Other applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Global G-protein coupled receptors market: Regional movement analysis
  • Fig. 42 Global G-protein coupled receptors market: Regional outlook and key takeaways
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-3-68038-224-2

G-Protein Coupled Receptors Market Growth & Trends:

The global G-protein coupled receptors market size is expected to reach USD 5.23 billion by 2030 registering a CAGR of 5.1%, according to a new report by Grand View Research, Inc.. Rising adoption of faster and accurate High-Throughput Screening (HTS) technology by pharmaceutical firms to develop potential G-protein coupled receptor(GPCR)-targeted therapeutics is expected to augment the market growth. HTS is used on the G-protein coupled receptor cell-based assays to assist several drug development programs.

Structural and functional features of G-protein coupled receptors (GPCRs) allow it to mediate physiological responses to hormones, stimulants, and neurotransmitters, thus making them as potential therapeutic targets for various diseases. Recent advancements in the structural biology of GPCRs have provided insights into the molecular mechanisms of these receptors' activation and activity. Several pharmaceutical companies are undertaking efforts to develop G-protein coupled receptors-targeted therapeutics for several disorders.

In December 2018, Boehringer Ingelheim collaborated with Domain Therapeutics to discover GPCR targets for the treatment of cancer, Central Nervous System (CNS), and immunological disorders. Moreover, in May 2019, Evotec OAI AG partnered with Euroscreen S.A. to improve its capabilities for GPCR targeting. Evotec OAI will access GPCR reagents and AequoScreenTM technology of Euroscreen for its drug discovery procedures. Such initiatives enhance the product adoption as well as drug screening expertise in the pharmaceutical industry.

North America is likely to be at the forefront of the market throughout the forecast period due to heavy investments in cancer research to address the rising demand for drug discovery and development procedures in U.S. Whereas, Asia Pacific is expected to register the fastest CAGR over the forecast years. The region witnesses a rising number of therapeutics development and contract research, thus boosting G-protein coupled receptors market growth.

G-Protein Coupled Receptors Market Report Highlights:

  • Easy availability of cell lines products and a large number of companies offering a variety of cell lines resulted in the largest revenue share of cell lines in 2022
  • Increasing usage of fully equipped detection kits instead of cell lines, reagents, and ligands separately, marks the potential growth of detection kits in the near future
  • cAMP assays serve as a versatile platform in HTS for explaining the GPCR functions, which results in maximum revenue generation from these type of assays
  • Cancer research application accounted for the largest revenue share in 2022 owing to increased number of cancer cases and investments in oncology R&D
  • Ongoing research studies to evaluate the pharmacology of GPCRs in chronic inflammatory disorders reveals immense opportunities for research in inflammatory applications
  • Acquisition, partnerships, and collaborations are the major strategies adopted by these companies to offer new GPCR-targeted medicines, thereby strengthening their presence in the global GPCRs market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Assay Type
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Assay type outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. G-protein Coupled Receptors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. G-protein Coupled Receptors Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. G-protein Coupled Receptors Market: Product Estimates & Trend Analysis

  • 4.1. G-protein Coupled Receptors Market: Key Takeaways
  • 4.2. G-protein Coupled Receptors Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Cell lines
    • 4.3.1. Cell lines market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Detection kits
    • 4.4.1. Detection kits market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Cell Culture Reagents
    • 4.5.1. Cell culture reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Ligands
    • 4.6.1. Ligands market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. G-protein Coupled Receptors Market: Assay Type Estimates & Trend Analysis

  • 5.1. G-protein Coupled Receptors Market: Key Takeaways
  • 5.2. G-protein Coupled Receptors Market: Assay Type Movement & Market Share Analysis, 2022 & 2030
  • 5.3. cAMP Functional Assays
    • 5.3.1. cAMP functional assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Calcium Functional Assays
    • 5.4.1. Calcium functional assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. B-Arrestin Functional Assays
    • 5.5.1. B-Arrestin functional assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Radioligand Binding and GTPγS Functional Assays
    • 5.6.1. Radioligand binding and GTPγS functional assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Internalization Assays
    • 5.7.1. Internalization assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Trafficking Assays
    • 5.8.1. Trafficking assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Other Assays
    • 5.9.1. Other assays market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. G-protein Coupled Receptors Market: Application Estimates & Trend Analysis

  • 6.1. G-protein Coupled Receptors Market: Key Takeaways
  • 6.2. G-protein Coupled Receptors Market: Application Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Cancer Research
    • 6.3.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. CNS Research
    • 6.4.1. CNS research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Metabolic Research
    • 6.5.1. Metabolic research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Cardiovascular Research
    • 6.6.1. Cardiovascular research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Inflammation Research
    • 6.7.1. Inflammation research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Respiratory Research
    • 6.8.1. Respiratory research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9. Other Applications
    • 6.9.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. G-protein Coupled Receptors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. G-protein Coupled Receptors Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. UK
      • 7.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. France
      • 7.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. China
      • 7.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. India
      • 7.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. South Africa
      • 7.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Thermo Fisher Scientific Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Eurofins Scientific
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. QIAGEN
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. WuXi AppTec
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Promega Corporation
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Abcam plc
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Merck KGaA
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. PerkinElmer Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Enzo Biochem Inc.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. BD
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives